Latest News about PSYGF
Recent news which mentions PSYGF
Psychedelics Headlines: Anti-inflammatory Effects, Global Drug Survey, 'Synthetic Surprise,' UK's Harm Reduction Hub And More
January 26, 2024
From Benzinga
From Benzinga
From Benzinga
Psychedelic Research Expands In Australia With Palliative Care Partnership & New MDMA Analog Portfolio
March 21, 2023
From Benzinga
Psychedelics Update: MDMA Export, 3D Farm, Recovery Center Reopens, Mushroom Extraction & E-Commerce
January 24, 2023
From Benzinga
Psychedelics Travel: Clinical-Grade Magic Mushrooms Extract Exported From Southern Africa To UK
January 20, 2023
Tickers
PSYGF
From Benzinga
From Benzinga
Psyched: First Ayahuasca Pill Created, Psychedelics Legalization Predicted, UK's Research Support And More
December 19, 2022
From Benzinga
Psyence, Revive Therapeutics Ink Private Placements: Capital To Support Drug Trials
December 16, 2022
From Benzinga
From Benzinga
European Psychedelics Research Group Nabs $2M In Seed Funding As Clinical Research Picks Up Speed
October 11, 2022
From Benzinga
International Magic Mushrooms: Where Are They Produced And Where Are They Headed?
September 29, 2022
Tickers
PSYGF
From Benzinga
Psyched: Magic Mushrooms Vs. Psychotherapy, Psilocybin For Frontline Health Workers & Protecting Peyote
September 26, 2022
Tickers
PSYGF
From Benzinga
Magic Mushrooms Vs. Psychotherapy For Incurable Cancer Diagnosis Moves Forward In UK Clinical Trials
September 19, 2022
Tickers
PSYGF
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.